JP2007530971A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007530971A5 JP2007530971A5 JP2007506111A JP2007506111A JP2007530971A5 JP 2007530971 A5 JP2007530971 A5 JP 2007530971A5 JP 2007506111 A JP2007506111 A JP 2007506111A JP 2007506111 A JP2007506111 A JP 2007506111A JP 2007530971 A5 JP2007530971 A5 JP 2007530971A5
- Authority
- JP
- Japan
- Prior art keywords
- exchange chromatography
- liquid
- ion exchange
- matrix
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400886A SE0400886D0 (sv) | 2004-04-02 | 2004-04-02 | Process of purification |
| SE0400886-8 | 2004-04-02 | ||
| PCT/SE2005/000467 WO2005094960A1 (en) | 2004-04-02 | 2005-03-31 | A method for chromatographic purification |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007530971A JP2007530971A (ja) | 2007-11-01 |
| JP2007530971A5 true JP2007530971A5 (enExample) | 2008-05-15 |
| JP4831697B2 JP4831697B2 (ja) | 2011-12-07 |
Family
ID=32173667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007506111A Expired - Lifetime JP4831697B2 (ja) | 2004-04-02 | 2005-03-31 | 精製方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070213513A1 (enExample) |
| EP (1) | EP1729867B1 (enExample) |
| JP (1) | JP4831697B2 (enExample) |
| AT (1) | ATE485880T1 (enExample) |
| AU (1) | AU2005228834A1 (enExample) |
| CA (1) | CA2560012A1 (enExample) |
| DE (1) | DE602005024373D1 (enExample) |
| SE (1) | SE0400886D0 (enExample) |
| WO (1) | WO2005094960A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
| EP2500413A1 (en) | 2006-09-13 | 2012-09-19 | Abbott Laboratories | Cell culture improvements |
| WO2008156410A1 (en) * | 2007-06-19 | 2008-12-24 | Ge Healthcare Bio-Sciences Ab | Polymer two phase system and use thereof |
| WO2009090056A2 (en) * | 2008-01-18 | 2009-07-23 | F. Hoffmann-La Roche Ag | Purification of not-glycosylated polypeptides |
| WO2009099375A1 (en) * | 2008-02-05 | 2009-08-13 | Ge Healthcare Bio-Sciences Ab | Method for production of separation media |
| FR2930780B1 (fr) * | 2008-04-30 | 2010-08-20 | Moet & Chandon | Procede de degorgement de vins mousseux |
| US20090318674A1 (en) * | 2008-06-03 | 2009-12-24 | Gagnon Peter S | Process for purification of antibodies |
| KR20110091678A (ko) * | 2008-10-20 | 2011-08-12 | 아보트 러보러터리즈 | 단백질 ａ 친화성 크로마토그래피를 이용한 항체의 분리 및 정제 |
| NZ592097A (en) | 2008-10-20 | 2013-01-25 | Abbott Lab | Viral inactivation during purification of il-12 and il-18 antibodies |
| ES2865449T3 (es) | 2011-03-16 | 2021-10-15 | Hoffmann La Roche | Cromatografía de intercambio iónico con selectividad mejorada para la separación de monómeros, agregados y fragmentos polipeptídicos por modulación de la fase móvil |
| CN107915769A (zh) | 2011-03-29 | 2018-04-17 | 葛兰素史密斯克莱有限责任公司 | 用于蛋白纯化的缓冲液体系 |
| EP3210662A1 (en) * | 2011-06-08 | 2017-08-30 | Agency For Science, Technology And Research | Purification of biological products by constrained cohydration chromatography |
| EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
| US10023608B1 (en) | 2013-03-13 | 2018-07-17 | Amgen Inc. | Protein purification methods to remove impurities |
| EP3048109A4 (en) * | 2013-09-17 | 2017-04-19 | Kaneka Corporation | Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom |
| TW201628649A (zh) | 2014-10-09 | 2016-08-16 | 再生元醫藥公司 | 減少醫藥調配物中微可見顆粒之方法 |
| KR102369014B1 (ko) | 2016-08-16 | 2022-03-02 | 리제너론 파아마슈티컬스, 인크. | 혼합물로부터 개별 항체들을 정량하는 방법 |
| ES3032778T3 (en) | 2016-10-25 | 2025-07-24 | Regeneron Pharma | Methods for chromatography data analysis |
| MY203415A (en) | 2017-09-19 | 2024-06-27 | Regeneron Pharma | Methods of reducing particle formation and compositions formed thereby |
| CN108152104B (zh) * | 2017-12-25 | 2020-08-11 | 上海微谱化工技术服务有限公司 | 超支化水性聚氨酯中二氧化硅填料的分离及定量方法 |
| CN119881293A (zh) | 2018-03-21 | 2025-04-25 | 沃特世科技公司 | 基于非抗体高亲和力的样品制备、吸附剂、装置和方法 |
| US11420916B2 (en) * | 2018-06-08 | 2022-08-23 | Board Of Regents, The University Of Texas System | Systems and methods for separation of olefins from mixtures that contain reducing agents |
| TW202448568A (zh) | 2018-07-02 | 2024-12-16 | 美商里珍納龍藥品有限公司 | 自混合物製備多肽之系統及方法 |
| EP4038082A1 (en) * | 2019-10-04 | 2022-08-10 | Merck Patent GmbH | Elution of monoclonal antibodies in protein a affinity chromatography |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3869436A (en) * | 1971-06-01 | 1975-03-04 | Statens Bakteriologiska Lab | Method for fractionating plasma proteins using peg and ion-exchangers |
| DE3483620D1 (de) * | 1983-03-11 | 1991-01-03 | Fujirebio Kk | Verfahren zur bestimmung von liganden. |
| US4683294A (en) * | 1985-04-03 | 1987-07-28 | Smith Kline Rit, S.A. | Process for the extraction and purification of proteins from culture media producing them |
| DE3789413T2 (de) * | 1986-10-03 | 1994-07-28 | Ciba Geigy Ag | Lymphokin-ähnliche Peptide. |
| US5151358A (en) * | 1989-06-13 | 1992-09-29 | Genencor International, Inc. | Processes for the recovery of naturally produced chymosin |
| DE4321904B4 (de) * | 1993-07-01 | 2013-05-16 | Qiagen Gmbh | Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen |
| US5443953A (en) * | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
| US5561064A (en) * | 1994-02-01 | 1996-10-01 | Vical Incorporated | Production of pharmaceutical-grade plasmid DNA |
| US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
| SE9503925D0 (sv) * | 1995-11-07 | 1995-11-07 | Pharmacia Biotech Ab | Separationsmedium för IgG |
| US20020006405A1 (en) * | 1996-10-22 | 2002-01-17 | Masaki Kitajima | Sepsis remedy comprising anti-il-8 antibody as active ingredient |
| AUPR110100A0 (en) * | 2000-10-30 | 2000-11-23 | Life Therapeutics Limited | Improved separation of macromolecules |
| US7514078B2 (en) * | 2001-06-01 | 2009-04-07 | Cornell Research Foundation, Inc. | Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| US7998705B2 (en) * | 2002-08-06 | 2011-08-16 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc | Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol |
| US20060275766A1 (en) * | 2003-01-07 | 2006-12-07 | Haurum John S | Method for manufacturing recombinant polyclonal proteins |
-
2004
- 2004-04-02 SE SE0400886A patent/SE0400886D0/xx unknown
-
2005
- 2005-03-31 EP EP05722292A patent/EP1729867B1/en not_active Expired - Lifetime
- 2005-03-31 DE DE602005024373T patent/DE602005024373D1/de not_active Expired - Lifetime
- 2005-03-31 US US10/594,187 patent/US20070213513A1/en not_active Abandoned
- 2005-03-31 WO PCT/SE2005/000467 patent/WO2005094960A1/en not_active Ceased
- 2005-03-31 AU AU2005228834A patent/AU2005228834A1/en not_active Abandoned
- 2005-03-31 AT AT05722292T patent/ATE485880T1/de not_active IP Right Cessation
- 2005-03-31 CA CA002560012A patent/CA2560012A1/en not_active Abandoned
- 2005-03-31 JP JP2007506111A patent/JP4831697B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007530971A5 (enExample) | ||
| Ma et al. | Immobilized enzyme reactors in proteomics | |
| CN104374848B (zh) | 一种苯硼酸材料富集糖肽的方法 | |
| JP2007525501A5 (enExample) | ||
| CN104096544A (zh) | 以氨基苯并咪唑为功能配基的层析介质及其制备方法 | |
| JP2008500554A5 (enExample) | ||
| JP2006512283A5 (enExample) | ||
| Krenkova et al. | Less common applications of monoliths: V. Monolithic scaffolds modified with nanostructures for chromatographic separations and tissue engineering | |
| Pluskal | Microscale sample preparation | |
| CN102183603B (zh) | 一种全氟毛细管萃取整体柱及其制备方法和应用 | |
| SE0400886D0 (sv) | Process of purification | |
| Kitte et al. | Recent advances in nanomaterial‐based capillary electrophoresis | |
| HRP20210849T1 (hr) | Afinitetna podloga i postupak hvatanja supstance korištenjem iste podloge | |
| Moravcová et al. | Monoliths in capillary electrochromatography and capillary liquid chromatography in conjunction with mass spectrometry | |
| Craft et al. | Microcolumn capture and digestion of proteins combined with mass spectrometry for protein identification | |
| Arrua et al. | Macroporous monolithic supports for affinity chromatography | |
| Li et al. | Novel nanomaterials used for sample preparation for protein analysis | |
| JP2008503754A5 (enExample) | ||
| Cingöz et al. | Evaluation of various immobilized enzymatic microreactors coupled on-line with liquid chromatography and mass spectrometry detection for quantitative analysis of cytochrome c | |
| Dong et al. | Functionalizing microporous membranes for protein purification and protein digestion | |
| Liu et al. | Effects of spacer arm on penicillin G acylase purification using immobilized metal affinity membranes | |
| SE9904272D0 (sv) | A method for selective removal of a substance from samples containing compounds having nucleic acid structure | |
| Kuban et al. | Ni (II) functionalized polyhedral oligomeric silsesquioxane based capillary monolith for purification of histidine-tagged proteins by immobilized metal affinity micro-chromatography | |
| CN1876674A (zh) | 一种天然防腐剂的工业化纯化工艺 | |
| SE0402558D0 (sv) | A process for the purification of antibodies |